Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by Bitofgreenon Sep 27, 2019 11:16am
86 Views
Post# 30170762

RE:RE:Aphria stock received increased coverage from analysts.

RE:RE:Aphria stock received increased coverage from analysts.Sky, takes serious money to manufacture the numbers showing up on the black market.  Authorities need to follow the money, as these products seem to have a well-defined supply chain.  Makes me question the timing of the health issues. It’s not like these products are just showing up. Press are on payrolls of the highest bidder. 


skyplt wrote: The sad irony is I just took a look at both APHA and WEED's stock price.  Despite Aphria having a positive outlook, and WEED getting a downgrade, at this moment APHA is down more than WEED percentage wise.

This sh!t is growing old.

In a perfect world we would see Double Diamond approval at 5pm, Irwin Simon give a stellar interview shortly after, then a jaw dropping short burning quarterly report.

Unfortunately, this past year has proven we do not live in a perfect world.

By the way, I find it interesting that the article about certain ingredients in black market cartridges (and not THC) may be the culprit of vaping issues is not getting nearly the press the scare articles did.

This whole sector feels rigged...but I do believe Aphria will persevere and thrive.


Daredevil1964 wrote: The company has a positive outlook for fiscal 2020. Also, Aphria expects to fulfill its annual production capacity after all of its facilities are fully licensed. The expectations might have increased analysts’ confidence.




Bullboard Posts